News & Alerts
-
Oct- 2023 -31 October
Generalized Anxiety Disorder Treatment Market Poised for Positive Growth from 2023 to 2032, Says DelveInsight Report
Generalized Anxiety Disorder Treatment Market is poised for positive growth during the forecast period from 2023 to 2032. This is…
Read More » -
30 October
FDA Cautions Against Buying Specific Eye Drops Due to Infection Concerns
The U.S. Food and Drug Administration (FDA) issued a warning on October 27, 2023, advising consumers not to purchase or…
Read More » -
27 October
Gastroparesis Treatment Market to Reach USD 11.09 Billion by 2030
Infinium Global Research, a leading market research firm, has recently released a comprehensive report on the Gastroparesis Treatment Market. The…
Read More » -
26 October
Fundamental Changes To Medicare’s Part D Drug Benefits for 2024
Image Source Medicare open enrollment is here. It’s time again to review your options and make any necessary changes to…
Read More » -
26 October
West Pharmaceutical Services Boosts 2023 Profit Forecast Amidst Shifting Market Dynamics
West Pharmaceutical Services (WST.N), a leading medical equipment maker, announced on Thursday that it has revised its 2023 adjusted profit…
Read More » -
25 October
Demand for RSV Protection Shot for Babies Outpaces Supply, Prompts CDC Recommendation
In response to soaring demand, the supply of nirsevimab (Beyfortus), a novel vaccine designed to safeguard babies against respiratory syncytial…
Read More » -
25 October
International Flavors & Fragrances (IFF) Explores Potential $3.5 Billion Sale of Pharma Solutions Business
International Flavors & Fragrances (IFF.N) has initiated discussions with an advisor to consider the possibility of selling its pharma solutions…
Read More » -
25 October
Royalty Pharma Expands Ownership of Evrysdi Royalties with $1 Billion Investment in Roche SMA Drug
Royalty Pharma (RPRX.O) has announced the acquisition of additional royalties for Roche (ROG.S) and PTC Therapeutics’ (PTCT.O) oral spinal muscular…
Read More » -
25 October
UNION Therapeutics to Present at 7th Annual Dermatology Drug Development Summit in Boston
HELLERUP, Denmark, Oct. 25, 2023. UNION Therapeutics A/S (UNION), a leading clinical-stage pharmaceutical development company specializing in immunology and infectious…
Read More » -
24 October
Upcoming Event: 1st Academic Conference of Safety Psychology and Behavior for Healthcare
The International Association of Risk Management in Medicine (IARMM) has announced the Joint Conference for Clinical Safety Promotion, featuring the…
Read More »